The European Investment Bank (EIB) has granted German biotech CureVac a €75 million loan to support its ongoing development of vaccines against infectious diseases...
US-based CDMO Catalent has agreed a collaboration with US biotech Moderna for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine...
Sanofi Pasteur, the vaccines global business unit of French drugmaker Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, are formally...
German biotech BioNTech, which is working on developing an mRNA vaccine against Covid-19 and has aligned itself with US pharma major Pfizer, this week raised $250 million...
17.06.2020
- The German federal government is taking a 23.1% stake, worth €300 million, in privately owned biotech CureVac. It’s an unusual move for Berlin, but economics minister Peter...
Read the digital edition of CHEManager International. Simply enter the subscription number or promotional code and login. You will find your subscription number on your invoice, or a previous print edition. The promotional code is '247'.
09.06.2020
- Anglo-Swedish drugmaker AstraZeneca is weighing a merger with US biotech Gilead Sciences, the Bloomberg news agency has reported. Surpassing Bristol Myers Squibb’s $74 billion...
09.06.2020
- Pierre-Alain Ruffieux has been appointed CEO of Swiss CDMO Lonza, with effect from 1 November 2020. The new chief executive will succeed Marc Funk, who led the company from March...
